Related Experiment Video
Updated: Aug 19, 2026
06:15
Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus
Published on: March 6, 2019
Jeune syndrome (asphyxiating thoracic dystrophy) associated with Hirschsprung disease
1Great Ormond Street Hospital for Children, London, UK.
Clinical Dysmorphology
|October 26, 1999
Insights
This study reports two children with Jeune syndrome and Hirschsprung disease, a previously undescribed association. This finding may impact clinical care and future research for these rare genetic conditions.
Area of Science:
- Pediatric genetics
- Gastroenterology
- Rare disease research
Background:
- Jeune syndrome, also known as asphyxiating thoracic dystrophy, is a rare skeletal ciliopathy.
- Hirschsprung disease is a congenital disorder characterized by the absence of ganglion cells in the distal colon.
Observation:
- Two pediatric patients presented with clinical features consistent with Jeune syndrome.
- Both patients were also diagnosed with Hirschsprung disease.
Findings:
- This case series describes a novel co-occurrence of Jeune syndrome and Hirschsprung disease.
- The association between these two distinct conditions has not been previously documented in medical literature.
Implications:
- The identified association suggests potential shared genetic or developmental pathways.
- This finding necessitates consideration of Hirschsprung disease in patients with Jeune syndrome and vice versa.
- Further research is warranted to elucidate the underlying mechanisms connecting these two rare disorders.
Abstract:
We describe two children with diagnostic features of Jeune syndrome who also had Hirschsprung disease. An association between the two conditions has not previously been described and has implications both for clinical management and for further study.
Related Concept Videos
01:27Pneumothorax-II
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Clinical Manifestations:
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
01:29Respiratory Syncytial Virus Disease
Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
01:08Pneumothorax II: Pathophysiology
Pneumothorax means the presence of air in the pleural space — the thin potential gap between the visceral and parietal pleura. This condition disrupts the normal pressure balance that keeps the lungs inflated, leading to partial or complete collapse of the affected lung.Normal physiologyUnder normal conditions, the pleural space maintains a slightly negative intrapleural pressure, which keeps the lungs expanded against the chest wall. This negative pressure creates a delicate balance between...
01:10Atelectasis II: Pathophysiology
Atelectasis develops when alveoli lose their air and collapse inward. Because lung tissue is naturally elastic, these air sacs shrink rather than remaining open. Collapsed alveoli are no longer ventilated, reducing their role in gas exchange. Blood flow may continue in these regions, creating a ventilation–perfusion mismatch. Clinical findings include decreased breath sounds, dullness to percussion, reduced chest expansion, and decreased tactile fremitus as sound transmission through collapsed...
01:27Esophageal Achalasia
Esophageal achalasia is a chronic neurogenic disorder characterized by impaired relaxation of the lower esophageal sphincter (LES) and absent or ineffective peristalsis in the distal esophagus. This leads to a functional obstruction without a physical blockage, despite significant disruption of esophageal motility.EtiologyAchalasia is caused by degeneration of the myenteric (Auerbach's) plexus, specifically the loss of inhibitory ganglion cells that produce vasoactive intestinal peptide (VIP)...